Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 14 ... trapped and vaccinated using a prototype oral-delivery system to deliver the Tb vaccinebacilleCalmette-Guerin. Vaccinated and control possums were matched according to age, sex and ...
2009 AUG 24 ... to estimate national coverage with routine service delivery of the following vaccines: bacilleCalmette-Guerin; diphtheria-tetanus-pertussis, first and third doses; either oral polio ... Calmette-Guerin; diphtheria-tetanus-pertussis, first and third doses; either oral polio vaccine or inactivated polio vaccine, third dose of either; hepatitis B, third dose; Haemophilus ...
2009 MAR 30 ... using peripheral blood mononuclear cells (PBMCs) obtained from 72 Mycobacterium bovis Bacille Calmette-Guérin vaccinated healthy subjects."
"PBMCs were tested ... in antibody assays in humans and animals and provides protection as a combined DNA vaccine in mice. This study was undertaken to determine the reactivity of MPT63 in T helper 1 ...
2009 JAN 19 ... (TB), the risk of travel-associated TB is of increasing concern. However, the use of Bacille Calmette-Guérin (BCG) vaccine for the prevention of travel-associated TB is a neglected ... Keywords: Australia, Tuberculosis Vaccines, BCG Vaccines, Bacillus Calmette-Guerin Vaccines, Biotechnology, Cutaneous Tuberculosis, Immunization, Infectious Disease, ...
2009 JUL 27 ... "One reason proposed for the failure of Mycobacterium bovis bacille Calmette Guerin (BCG) vaccination to adequately control the spread of tuberculosis is a ... MD 20814, USA. Keywords: Australia, Sydney, BCG Vaccines, Bacillus Calmette-Guerin Vaccines, Biotechnology, Cutaneous Tuberculosis, Immunization, Immunology, Mycobacteria, ... vaccination to adequately control the spread of tuberculosis is a limited ability of the vaccine to induce effective CD8 T cell responses. However, the relative capacity of the BCG ...
2009 APR 27 ... are discussed in a new report. "This study examines the predictors of Bacille Calmette-Guérin (BCG) immunization status among infants in northern Nigeria using a ... CA 91320, USA.
Keywords: United States, Baltimore, BCG Vaccines, Bacillus Calmette-Guerin Vaccines, Behavior, Biotechnology, Child Health, Immunization, Pediatric Vaccines, ... model. The findings show only 37.3 percent of the children had received BCG vaccine, and reveal that BCG immunization status in northern Nigeria is influenced by multiple ...
2009 APR 20 ... recent research published in the journal Nature Medicine, "The variable efficacy of Bacille Calmette Guerin ( BCG) vaccination against tuberculosis has prompted efforts to improve ... 10013-1917, USA.
Keywords: United States, Fannin, BCG Vaccines, Bacillus Calmette-Guerin Vaccines, Biotechnology, Cutaneous Tuberculosis, Immunization, Mycobacteria, ... Guerin ( BCG) vaccination against tuberculosis has prompted efforts to improve the vaccine. In this study, we used autophagy to enhance vaccine efficacy against tuberculosis in a ...
2009 AUG 3 ... of tuberculosis infection is seriously compromised because of extensive use of the bacilleCalmette-Guerin (BCG) vaccination. The interferon-gamma release assay (IGRA), a new ... Treatment, Vaccination, Virology. This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 MAY 4 ... deaths every year globally. A single licensed vaccine derived from Mycobacterium bovis, bacilleCalmette-Guerin (BCG) administered perinatally as a prophylactic vaccine has been in use ...
2009 MAY 4 ... "The immunogenicity of the recombinant BacilleCalmette-Guerin: rBCG-Ag85B-Mpt64(190-198)-Mtb8.4 (rBCG-AMM) was evaluated in our ... suggested that the recombinant BCG: rBCG-Ag85B-Mpt64(190-198)-Mtb8.4 is a potential vaccine candidate for further study."
Qie and colleagues published their study ...
2009 MAR 2 ... sex, contact, several genetic polymorphisms and area. Neither one nor two doses of the bacilleCalmette-Guerin (BCG) vaccine provides protection against adult pulmonary TB, despite ...
2009 MAR 30 ... Scientists discuss in 'More vaccine efficacy studies on the recombinant BacilleCalmette-Guerin co-expressing Ag85B, Mpt64 and Mtb8.4' new findings in vaccines. ...
2008 DEC 8 ... tuberculosis," researchers in Bulawayo, Zimbabwe report.
"A model with bacilleCalmette-Guerin (BCG) vaccination for the susceptibles and treatment for the infectives ... number is greater than unity From the stud we conclude that there pre-exposure vaccine currently under development coupled with chemoprophylaxis for the latently infected and ...
2008 OCT 6 ... new data in Bacillus calmette-guerin. According to a study from Australia, "The Bacille Calmette-Guérin (BCG) vaccine has been used for more than 80 years to protect against ...
2008 NOV 3 ... vaccinated a total of 35 study participants. The standard TB vaccine -- called BacilleCalmette-Guerin (BCG) -- was given to 17 study participants, and 18 study participants ...
2008 NOV 10 ... New investigation results, 'The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities ... 1GB, Oxon, England.
Keywords: Venezuela, Caracas, BCG Vaccines, Bacillus Calmette-Guerin Vaccines, Biotechnology, Cutaneous Tuberculosis, Immunization, Mycobacteria, ...
2008 NOV 10 ... the most important infectious diseases of man and animals. The current vaccine, M. bovis bacilleCalmette-Guerin (BCG) demonstrates variable efficacy in humans and cattle, and so an ...
2008 NOV 10 ... production in PBMC. To further augment the activating effects on Th1-type response, BacilleCalmette-Guerin (BCG) was utilized as a non-specific stimulus. Neu-Fc, IFN-gamma and BCG ... cell immune response, we used xenogeneic antigen rat neu L2-S2 domains as the vaccine antigen. The antigenic protein was engineered as a chimeric protein with human IgG1 Fc ...
2008 DEC 8 ... the results of their research in the Journal of Infectious Diseases (A New Recombinant Bacille Calmette-Guerin Vaccine Safely Induces Significantly Enhanced Tuberculosis-Specific Immunity in Human ...
